Back to Search
Start Over
Reward related ventral striatal activity and differential response to sertraline versus placebo in depressed individuals
- Source :
- Molecular psychiatry
- Publication Year :
- 2019
-
Abstract
- Medications to treat major depressive disorder (MDD) are not equally effective across patients. Given that neural response to rewards is altered in MDD and given that reward-related circuitry is modulated by dopamine and serotonin, we examined, for the first time, whether reward-related neural activity moderated response to sertraline, an antidepressant medication that targets these neurotransmitters. 222 unmedicated adults with MDD randomized to receive sertraline (n=110) or placebo (n=112) in the EMBARC (Establishing Moderators and Biosignatures of Antidepressant Response in Clinical Care) study completed demographic and clinical assessments, and pre-treatment functional magnetic resonance imaging while performing a reward task. We tested whether an index of reward system function in the ventral striatum (VS), a key reward circuitry region, moderated differential response to sertraline versus placebo, assessed with the Hamilton Rating Scale for Depression over 8 weeks. We observed a significant moderation effect of the reward index, reflecting the temporal dynamics of VS activity, on Week-8 depression levels (Fs≥9.67,ps≤0.002). Specifically, VS responses that were abnormal with respect to predictions from reinforcement learning theory were associated with lower Week-8 depression symptoms in the sertraline versus placebo arms. Thus, a more abnormal pattern of pre-treatment VS dynamic response to reward expectancy (expected outcome value) and prediction error (difference between expected and actual outcome), likely reflecting serotonergic and dopaminergic deficits, was associated with better response to sertraline than placebo. Pre-treatment measures of reward-related VS activity may serve as objective neural markers to advance efforts to personalize interventions by guiding individual-level choice of antidepressant treatment. Trial Registration: NCT01407094; http://clinicaltrials.gov/show/NCT01407094
- Subjects :
- 0301 basic medicine
Oncology
Adult
Male
medicine.medical_specialty
Placebo
Article
03 medical and health sciences
Cellular and Molecular Neuroscience
Reward system
0302 clinical medicine
Reward
Internal medicine
Sertraline
medicine
Humans
Molecular Biology
Depressive Disorder, Major
business.industry
Dopaminergic
Ventral striatum
Hamilton Rating Scale for Depression
medicine.disease
Antidepressive Agents
Psychiatry and Mental health
030104 developmental biology
medicine.anatomical_structure
Ventral Striatum
Major depressive disorder
Antidepressant
Female
business
030217 neurology & neurosurgery
medicine.drug
Subjects
Details
- Language :
- English
- ISSN :
- 14765578 and 13594184
- Volume :
- 25
- Issue :
- 7
- Database :
- OpenAIRE
- Journal :
- Molecular psychiatry
- Accession number :
- edsair.doi.dedup.....dfe8079d61339c11f0e2a358320574d0